Nexalin Technology, Inc. (NXL)
0.4981
+0.04
(+8.57%)
USD |
NASDAQ |
Feb 20, 16:00
0.5198
+0.02
(+4.36%)
After-Hours: 20:00
Nexalin Technology EPS Diluted (Quarterly) : -0.1279 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Standard BioTools, Inc. | -0.0906 |
| Ludwig Enterprises, Inc. | 0.00 |
| QHSLab, Inc. | 0.0017 |
| OpGen, Inc. | -0.0604 |
| Zomedica Corp. | -0.0062 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.276M |
| Revenue (Quarterly) | 0.0181M |
| Total Expenses (Quarterly) | 2.294M |
| Enterprise Value | 4.938M |
| Gross Profit Margin (Quarterly) | -2.41K% |
| Profit Margin (Quarterly) | -12.58K% |
| Earnings Yield | -118.6% |
| Normalized Earnings Yield | -118.63 |